153 related articles for article (PubMed ID: 23529605)
21. [Risks of infection caused by blood and blood products with reference to the so-called AIDS scandal].
Kretschmer V
Infusionsther Transfusionsmed; 1993 Dec; 20(6):286-90. PubMed ID: 8142734
[No Abstract] [Full Text] [Related]
22. Guidelines for administration of blood products: transfusion of infants and neonates. British Committee for Standards in Haematology Blood Transfusion Task Force.
Voak D; Cann R; Finney RD; Fraser ID; Mitchell R; Murphy MF; Napier JA; Phillips P; Rejman AJ; Waters AH
Transfus Med; 1994 Mar; 4(1):63-9. PubMed ID: 8012495
[No Abstract] [Full Text] [Related]
23. [Time to introduce audit of transfusion treatment. Local transfusion committees should be established in Sweden].
Schött U; Norda R; Ostlund I; Wikman A
Lakartidningen; 2010 Dec 15-21; 107(50):3216-20. PubMed ID: 21294336
[No Abstract] [Full Text] [Related]
24. Inactivation of pathogens in blood and blood products.
Ben-Hur E
Med Health R I; 1998 Dec; 81(12):396-9. PubMed ID: 9884539
[No Abstract] [Full Text] [Related]
25. [Good transfusion safety practices. Groupe Recherche et Démarche Qualité. Société Française de Transfusion Sanguine].
Rouger P
Transfus Clin Biol; 1999 Sep; 6(5):285-324. PubMed ID: 10528389
[No Abstract] [Full Text] [Related]
26. [Transfusion of blood and products derived from blood].
Wautier JL
Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
[No Abstract] [Full Text] [Related]
27. [Blood transfusion and blood product risks and alternatives (from the civil law viewpoint of the judge)].
Schlund GH
Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):M133-6. PubMed ID: 8001747
[No Abstract] [Full Text] [Related]
28. [Safety of blood transfusions; need for 'hemo-vigilance'].
van Aken WG; van Rood JJ
Ned Tijdschr Geneeskd; 1998 Feb; 142(6):281-4. PubMed ID: 9562726
[TBL] [Abstract][Full Text] [Related]
29. [Guidelines of the German Medical Association for Therapy with Blood Components and Plasma Derivatives--an introduction. Evidence-based recommendations for the risk-benefit analysis in hemotherapy].
Heim MU
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):186-97; quiz 199. PubMed ID: 19266420
[TBL] [Abstract][Full Text] [Related]
30. [Viral safety of blood and blood products].
Gürtler L
Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
[No Abstract] [Full Text] [Related]
31. [Immunobiology--the neglected side of transfusion].
Flesland O; Solheim BG
Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2493. PubMed ID: 11070981
[No Abstract] [Full Text] [Related]
32. [For a reform of the legislation applied to plasma derivatives].
Pellet R
Rev Neurol (Paris); 2009 May; 165 Suppl 3():S88-94. PubMed ID: 19524100
[TBL] [Abstract][Full Text] [Related]
33. Update on transfusion medicine.
Shander A; Goodnough LT
Pharmacotherapy; 2007 Sep; 27(9 Pt 2):57S-68S. PubMed ID: 17723109
[TBL] [Abstract][Full Text] [Related]
34. [Evolution of neonatal transfusion practices: current recommendations].
Plaisant F
Transfus Clin Biol; 2011 Apr; 18(2):262-8. PubMed ID: 21440478
[TBL] [Abstract][Full Text] [Related]
35. Improving transfusion practice with guidelines and prospective auditing by medical laboratory technologists.
Lin Y; Cserti-Gazdewich C; Lieberman L; Pendergrast J; Rammler W; Skinner I; Callum J
Transfusion; 2016 Nov; 56(11):2903-2905. PubMed ID: 28211959
[No Abstract] [Full Text] [Related]
36. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
[TBL] [Abstract][Full Text] [Related]
37. [Transfusion of homologous red cells: products, indications and alternatives].
Therapie; 2004; 59(3):349-73. PubMed ID: 15559188
[No Abstract] [Full Text] [Related]
38. [The transfusion law in Germany--an assessment].
Müller N
Zentralbl Chir; 2003 Jun; 128(6):459-61. PubMed ID: 12865949
[TBL] [Abstract][Full Text] [Related]
39. [Transfusion of blood and blood derivatives. Measurements of safety, circulatory, immunologic and infectious risks and accidents].
Rouger P; Hergon E
Rev Prat; 1997 Sep; 47(13):1499-504. PubMed ID: 9339033
[No Abstract] [Full Text] [Related]
40. Mechanisms and new approaches for the allogeneic blood transfusion-induced immunomodulatory effects.
Kao KJ
Transfus Med Rev; 2000 Jan; 14(1):12-22. PubMed ID: 10669937
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
